Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H.

Ann Surg. 2011 Sep;254(3):458-63; discussion 463-4. doi: 10.1097/SLA.0b013e31822c5d78.

PMID:
21865944
2.

Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS.

Circulation. 2004 Mar 30;109(12):1497-502. Epub 2004 Mar 8.

3.

Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial.

Desai SP, Henry LL, Holmes SD, Hunt SL, Martin CT, Hebsur S, Ad N.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):318-25. doi: 10.1016/j.jtcvs.2011.10.070. Epub 2011 Dec 3.

4.

Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.

Sokos GG, Bolukoglu H, German J, Hentosz T, Magovern GJ Jr, Maher TD, Dean DA, Bailey SH, Marrone G, Benckart DH, Elahi D, Shannon RP.

Am J Cardiol. 2007 Sep 1;100(5):824-9. Epub 2007 Jun 14.

PMID:
17719327
5.

Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.

Lecomte P, Foubert L, Coddens J, Dewulf B, Nobels F, Casselman F, Cammu G.

J Cardiothorac Vasc Anesth. 2011 Dec;25(6):937-42. doi: 10.1053/j.jvca.2011.03.173. Epub 2011 Jun 2.

PMID:
21640613
6.

Intraoperative glucose control in diabetic and nondiabetic patients during cardiac surgery.

Smith CE, Styn NR, Kalhan S, Pinchak AC, Gill IS, Kramer RP, Sidhu T.

J Cardiothorac Vasc Anesth. 2005 Apr;19(2):201-8.

PMID:
15868529
7.

Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery.

Knapik P, Nadziakiewicz P, Urbanska E, Saucha W, Herdynska M, Zembala M.

Ann Thorac Surg. 2009 Jun;87(6):1859-65. doi: 10.1016/j.athoracsur.2009.02.066.

PMID:
19463610
8.

Changing glucose control target and risk of surgical site infection in a Southeast Asian population.

Ng RR, Myat Oo A, Liu W, Tan TE, Ti LK, Chew ST.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):323-8. doi: 10.1016/j.jtcvs.2014.08.076. Epub 2014 Sep 17.

9.

Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.

Furnary AP, Zerr KJ, Grunkemeier GL, Starr A.

Ann Thorac Surg. 1999 Feb;67(2):352-60; discussion 360-2.

PMID:
10197653
10.

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A.

J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21.

11.

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C.

Diabetes. 1999 Jun;48(6):1289-94.

PMID:
10342818
12.

Impact of diabetes on 12-month outcomes following coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry.

Gitman MR, Okrainec K, Nguyen H, Duerr R, Del Core M, Fourchy D, Huynh T, Lader E, Rogers FJ, Chaudry MR, Pilote L, Eisenberg MJ; ROSETTA-CABG Investigators.

Can J Cardiol. 2005 Nov;21(13):1169-74.

PMID:
16308592
13.

The effect of diabetic medications on creatine kinase-myocardial band levels in patients undergoing coronary artery bypass surgery.

Engoren M, Zacharias A, Habib RH, Schwann TA, Riordan CJ, Durham SJ, Shah A.

Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):793-6. doi: 10.1510/icvts.2009.211425. Epub 2009 Aug 6.

PMID:
19661119
14.

Blood glucose level on postoperative day 1 is predictive of adverse outcomes after cardiovascular surgery.

Frioud A, Comte-Perret S, Nguyen S, Berger MM, Ruchat P, Ruiz J.

Diabetes Metab. 2010 Feb;36(1):36-42. doi: 10.1016/j.diabet.2009.06.008. Epub 2010 Jan 27.

PMID:
20106702
15.

Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes.

McAlister FA, Man J, Bistritz L, Amad H, Tandon P.

Diabetes Care. 2003 May;26(5):1518-24.

PMID:
12716815
16.

Relevance of the Surgical Care Improvement Project on glycemic control in patients undergoing cardiac surgery who receive continuous insulin infusions.

McDonnell ME, Alexanian SM, Junqueira A, Cabral H, Lazar HL.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):590-4; discussion 595-7. doi: 10.1016/j.jtcvs.2012.09.031. Epub 2012 Oct 9.

17.

Usefulness of perioperative blood glucose control in patients undergoing off-pump coronary artery bypass grafting.

Fujii T, Watanabe Y, Shiono N, Kawasaki M, Yokomuro H, Ozawa T, Hamada S, Masuhara H, Koyama N.

Gen Thorac Cardiovasc Surg. 2007 Oct;55(10):409-15.

PMID:
18018604
18.

Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG).

Cohen O, Dankner R, Chetrit A, Luxenburg O, Langenauer C, Shinfeld A, Smolinsky AK.

Cardiovasc Surg. 2003 Jun;11(3):195-200.

PMID:
12704328
19.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
20.

Effects of moderate intensity glycemic control after cardiac surgery.

Leibowitz G, Raizman E, Brezis M, Glaser B, Raz I, Shapira O.

Ann Thorac Surg. 2010 Dec;90(6):1825-32. doi: 10.1016/j.athoracsur.2010.07.063.

PMID:
21095319

Supplemental Content

Support Center